# PENEM DERIVATIVES

## Claims
Patentansprüche für folgende Vertragsstaaten BE, CH, DE, FR, GB, IT, LI, NL, SE

## Description
The present invention relates to new penem compounds, to processes for their preparation, and to pharmaceutical and veterinary compositions containing them. FR A 2122196 relates to antibacterial carbapenem derivatives characterised by a 2 substituent of the formula in which A represents cyclopentylene, cyclohexylene or C₂ C₆ alkylene optionally substituted by one or more C₁ C₄ alkyl groups R⁵ represents either a an optionally substituted aliphatic, cycloaliphatic, cycloaliphatic aliphatic, aryl, araliphatic, heteroaryl, heteroaliphatic, heterocyclyl or heterocyclyl aliphatic radical or b a divalent phenylene or C₁ C₄ alkylene group joined to the ring so as to form a bridged polycyclic group, and represents a quaternized nitrogen containing non aromatic heterocycle. The compounds of the invention are quaternary ammonium carboxylates of the following formula Z and their pharmaceutically or veterinarily acceptable salts wherein X is sulphur or oxygen group, wherein The present invention includes all the possible geometrical and optical isomers of the compounds of formula I , either in the form of isomeric mixtures or in the form of the individual separated isomers. Preferably, the compounds of formula I have a 5R,6S configuration. The preferred R group is an α hydroxy ethyl radical and this radical preferably has a 1R configuration, i.e. a R configuration at the α carbon atom of the ethyl group. As already said also the pharmaceutically or veterinarily acceptable salts of the compounds of formula I are included within the scope of the invention. The said salts may be both salts with acids, either inorganic acids such as, e.g., acetic, citric, tartaric, fumaric or methanesulphonic acid, and salts with bases, either inorganic bases such as, e.g. alkali or alkaline earth metal hydroxides, in particular sodium and potassium hydroxides, or organic bases such as, e.g., triethylamine, pyridine, benzylamine or collidine, including aminoacids such as, e.g., lysine or procaine. The invention includes also internal salts, i.e. zwitterions. In the present specification, the term halogen preferably encompasses fluorine and chlorine atom, but also iodine and bromine atoms. The alkyl groups, including the aliphatic moieties of the alkoxy, alkylthio and alkanoyl groups, may be branched or straight chain. A C₁ C₄ alkyl group is, preferably, methyl or ethyl. The term aryl encompasses, preferably, phenyl and naphthyl groups. The heterocyclic rings may be saturated or unsaturated, may have from 4 to 7 members and may contain from 1 to 4 heteroatoms selected from oxygen, nitrogen and sulphur atom. A C₁ C₄ alkoxy group is, preferably, methoxy or ethoxy. A protected hydroxy group may be a hydroxy group protected by a protecting group chosen, for instance, from an optionally substituted, especially halo substituted, acyl group, e.g., acetyl, monochloroacetyl, dichloroacetyl, trifluoroacetyl, benzoyl or p bromophenacyl a triarylmethyl group, in particular triphenylmethyl a silyl group, in particular trimethylsilyl, dimethyl tert butylsilyl, diphenyl tert butyl silyl or also a group such as tert butoxy carbonyl, p nitro benzyloxycarbonyl, 2,2,2 trichloroethoxycarbonyl, allyloxycarbonyl, benzyloxycarbonyl, and pyranyl. Preferred protecting groups of the hydroxy function are p nitro benzyloxycarbonyl dimethyl tert butyl silyl diphenyl tert butyl silyl trimethyl silyl allyloxy carbonyl benzyloxycarbonyl p bromo phenacyl triphenylmethyl and pyranyl. Preferred classes of compounds under this invention include compounds of formula I wherein wherein In general, preferred values for Z are those shown above under a , c and e . Also in general, preferred values for R₁, R₂ and R₃ are those shown above under i , ii and iv . Specific examples of preferred compounds of the invention are listed in the following table The compounds of formula I and their pharmaceutically and veterinarily acceptable salts can be prepared by a process comprising reacting a compound of formula II wherein R₁, R₂, R₃ are as defined above, with a penem intermediate of formula III wherein R, X and A are as defined above, Z is a carboxy protecting group, and L is a leaving group susceptible of nucleophilic displacement by the amine of formula II , and then removing the protecting groups therein present and, if desired, converting an obtained compound of formula I into a said salt thereof and or, if desired, separating a mixture of isomers of a compound of formula I or a said salt thereof into the single isomers. The leaving group L in the compound of formula III may be, for example, a sulphonyloxy group OSO₂R , wherein R is a substituted or unsubstituted alkyl or aryl group or a halogen atom such as iodine, bromine, chlorine. A particularly preferred sulphonyloxy group is trifluoromethanesulphonyloxy, OSO₂CF₃. A particularly preferred halogen atom is iodine. A carboxy protecting group Z may be any group which, together with the CO₂ moiety, forms an esterified carboxy group. Examples of carboxy protecting groups are, in particular, C₁ C₆ alkyl groups, for instance methyl, ethyl or tert butyl halo substituted C₁ C₆ alkyl groups, for example 2,2,2 trichloroethyl C₂ C₄ alkenyl groups, for example allyl optionally substituted aryl groups, for example phenyl and p nitro phenyl optionally substituted aryl C₁ C₆ alkyl groups, for example benzyl, p nitro benzyl and p methoxy benzyl aryloxy C₁ C₆ alkyl groups, for example phenoxy ethyl or groups such as benzhydryl, Particularly preferred carboxy protecting groups are allyl, When in the compound of formula III R is a C₁ C₃ alkyl group substituted by hydroxy, the hydroxy is preferably protected, and a particularly preferred protecting group is dimethyl tert butyl silyl. The reaction between a compound of formula II and a compound of formula III , may be performed in a suitable organic, preferably aprotic, solvent which may be, for instance, tetrahydrofuran, dimethylformamide, acetone or a halogenated hydrocarbon such as, e.g., dichloromethane. The reaction temperature may, preferably, vary between about 100 C and about 40 C, preferably between 70 C and 15 C. A compound of formula III wherein L is a sulphonyloxy group may be prepared reacting, according to known and conventional procedures, a carbinol precursor of formula IV wherein R, X, A and Z are as defined above, with the appropriate sulphonyl anhydride or sulphonyl halide, preferably triflic anhydride, a triflic chloride, in the presence of a non nucleophilic acid acceptor which may be, for instance, an inorganic base such as, e.g., calcium or lithium carbonate or calcium oxide, or an organic base such as, e.g., 2,6 lutidine or also the same compound of formula II to be reacted in the subsequent step. Indeed, according to a preferred procedure of the invention the compound of formula IV is made to react with the suitable sulphonyl anhydride or sulphonyl halide in the presence of an excess, usually an amount equal to or greater than 2 molar equivalents, of the desired compound of formula II in this situation the compound of formula III is not even isolated from the reaction mixture because it reacts The hereabove said preferred procedure is preferably carried out using dry dichloromethane as solvent at temperatures from about 70 C to 25 C. When a compound of formula II is reacted with a compound of formula III wherein L is halogen, the presence of a silver salt particularly if soluble in the media, e.g. AgClO₄, may be beneficial. A compound of formula III wherein L is halogen, may be prepared from the corresponding carbinol precursor of formula IV according to a modified Mitsunobu reaction, according to which this carbinol is allowed to react with an organic amine hydrohalide, such as, for instance, methoxyamine hydrochloride, pyridine hydrochloride, pyridine hydrobromide and the preformed complex obtained from diethylazodicarboxylate and triphenylphosphine, said reaction being carried out, e.g., in tetrahydrofuran or methylene chloride, preferably around room temperature. Alternatively, in the above modified Mitsunobu reaction a zinc halide, such as zinc chloride, zinc bromide and zinc iodide, can be substituted for the organic amine hydrohalide, under conditions substantially similar to those reported in Alternatively, a compound of formula III wherein L is halogen may be obtained from the carbinol of formula IV according to the more conventional procedures, entailing reaction with inorganic acid halides such as SOCl₂, PCl₅, PCl₃, PBr₃, POCl₃, POBr₃ and the like. An additional methodology well known in the literature, namely the reaction with PPh₃ in CCl₄, can be exploited for the preparation of compounds of formula III wherein L is chloride. A compound of formula III wherein L is iodine can be prepared by a halide exchange reaction from a compound of formula III wherein L is chlorine or bromine and sodium iodide, this reaction being preferably carried out in acetone at temperatures ranging from 0 C to 60 C reflux temperature . Some intermediates of formula III , preferably when L is chlorine, and the intermediates of formula IV , either as such or as their protected derivatives, are known compounds or can be prepared from known compounds by following known general methodologies. These include, for example, In particular, method A may be used to obtain intermediates for formula III and IV wherein X represents a sulphur atom methods B , C and D may be used to obtain intermediates of formula IV wherein X represents a sulphur atom method E may be used to obtain intermediates of formula III and IV wherein X represents an oxygen atom method F may be used to obtain intermediates of formula III and IV wherein A represents a group Removal of protecting groups can be effected by known The optional salification of an obtained compound and the separation of a mixture of isomers into the single isomers may be carried out following known and conventional procedures. Compounds of formula II , V , VI , VII , VIII , IX , X , XI , XII and XIII are known compounds or can be prepared from known compounds according to known methods. The compounds of formula I and their pharmaceutically and veterinarily acceptable salts provided by the present invention are potent, broad spectrum antibacterial agents. In comparison with other penem compounds, e.g. the sodium salts derived from penems of formula IV , or compounds of formula I wherein Q is an amine instead of quaternary ammonium, they usually show markedly increased Moreover, in comparison with other penem compounds, they show unusually prolonged plasma levels and, when tested The following table shows the activity of two typical compounds of formula I , the Compounds 1 and 31 of the previous table Compound 1 5R, 6S 6 1R hydroxyethyl 2 2 pyridinio ethylthio penem 3 carboxylate example 1 Owing to their high antibacterial activity the compounds of the invention are thus useful, for example, in the treatment of respiratory tract infections, for example, bronchitis, bronchopneumonia, pleuritis, hepatobiliary and abdominal infections, septicemia urinary tract infections, for example, pyelonephritis, cystitis obstetrical and gynecological infections, for instance, cervicitis, endometritis ear, nose and throat infections, for instance otitis, sinusitis, parotitis. The invention further provides pharmaceutical and veterinary compositions comprising a suitable carrier and or diluent and, as an active principle, a compound of the invention. The compounds of the invention may be administered, either to humans or to animals, in a variety of dosage forms, e.g., orally in the form of tablets, capsules, drops or syrups rectally in the form of suppositories parenterally, e.g., intravenously or intramuscularly as solutions or suspensions , with intravenous administration being preferred in emergency situation by inhalation in the form of areosols or solutions for nebulizers intravaginally in the form, e.g., of pessaries or topically in the form of lotions, creams and ointments. The pharmaceutical or veterinary compositions containing the compounds of the invention may be prepared in a conventional way by employing the conventional carriers or diluents used for, e.g., cephalosporins. Conventional carriers or diluents are, for example, water, gelatine, lactose, starches, magnesium stearate, talc, vegetable oils, cellulose and the like. Daily doses in the range of about 0.5 to about 100 mg per kg of body weight may be used, in various animal species, the exact dose depending on the age, weight and condition of the subject to be treated and on the frequency and route of administration. A preferred way of administration of the compounds of the invention is the parenteral one in this case the compounds may be administered, for example to adult humans, in an amount ranging from about 250 mg to about 1000 mg They are also useful as nutritional supplements in animal feeds. The following examples illustrate but do not limit the present invention. A solution of 80 m chloroperbenzoic acid 674 mg in dichloromethane was added under stirring to a cooled 20 C solution of allyl 5R, 6S 6 1R tert butyldimethylsilyloxyethyl 2 ethylthio penem 3 carboxylate 0.88 g in the same solvent 20 ml . After 20 minutes at 20 C, a further amount of the oxidant 50 mg was added, the solvent removed in vacuo without external cooling and the residue passed through a SiO₂ column, eluting with ethyl acetate cyclohexane mixtures, to obtain allyl 5R, 6S 6 1R tert butyldimethylsilyloxyethyl 2 ethylsulphynil penem 3 carboxylate as a syrup. This material 663 mg was dissolved in acetonitrile and treated at 40 under nitrogen with 2 mercaptoethanol 0,14 ml and diisopropylethylamine 0.25 ml , in this sequence. After 15 minutes at 40 , the reaction mixture was quenched with acetic acid and partitioned between water and ethyl acetate. The organic extracts were concentrated and the residue purified by flash chromatography thereby obtaining allyl 5R, 6S 6 1R tert butyldimethylsilyloxyethyl 2 2 hydroxyethylthio penem 3 carboxylate IR ν max CHCl₃ s 3400, 1790, 1690 cm ¹ NMR 60 MH Trifluoromethanesulphonic anhydride 0.44 ml and pyridine 0.47ml were added to a solution of the above intermediate 280 mg in dry dichloromethane at 40 in an argon atmosphere. The reaction mixture was left rise at 15 and kept at this temperature until all the starting material had disappeared TLC monitoring . A solution of 0.1M aqueous HCl 10 ml was then added, the organic layer was separated, washed with a further amount of 0.1M HCl, dried and evaporated. The resulting residue, consisting of crude allyl 5R, 6S 6 1R tert butyldimethylsilyloxyethyl 2 2 pyridinioethylthio penem 3 carboxylate chloride, was immediately dissolved in tetrahydrofuran 20 ml and stirred for 24 hours at room temperature in the presence of acetic acid 1 ml and tetrabutylammonium fluoride trihydrate 1.5 g . The solvent was removed in vacuo and the residue was purified by silica gel chromatography, eluting in sequence with CH₂Cl₂, CH₂Cl₂ MeCN, and aqueous MeCN, thereby obtaining the allyl ester of the title product IR ν max KBr 3400, 1785, 1690 cm ¹. This material 120 mg was stirred for 30 minutes at room temperature under nitrogen in a mixture of triphenylphosphine 20 mg tetrakis triphenylphosphine palladium 20 mg , and acetic acid 0.15 ml in 1 1 tetrahydrofurandichloromethane 8 ml . After filtering the catalyst, the solvent was removed and the residue dissolved in demineralized water, washed with dichloromethane, and passed through a reserve phase column LiChroprep RP 18 Merck, water and then 10 aq MeCN as eluants . The product containing fractions were collected and freeze dried to give the title compound 40 mg as a white powder UV max H₂O 320 nm NMR 200 MHz, D₂O, 45 C δ1.26 3H,d, Operating as described in the previous example, the following compounds were analogously prepared To a solution of allyl 5R,6S 6 1R tert butyldimethylsilyloxyethyl 2 2 hydroxyethylthio penem 3 carboxylate 450 mg in dry ethanol free dichloromethane 15ml there were added, at 30 under nitrogen, triethylamine 0.175 ml and methane sulphonylchloride 0.09 ml . The progress of the reaction was monitored by TLC when the starting material had disappeared, the reaction mixture was washed with diluted aq. NaHCO₃ and then with water. The organic phase was separated, dried over Na₂SO₄ evaporated to leave a residue which was purified by flash chromatography ethyl acetate cyclohexane mixtures , thereby obtaining allyl 5R,6S 6 1R tert butyldimethylsilyloxyethyl 2 2 methanesulphonyloxyethylthio penem 3 carboxylate. This compound 436 mg was immediately dissolved in dry acetone 25 ml and heated under argon in the presence of sodium iodide 260 mg at 40 for several hours. When the reaction was over NMR monitoring , the solvent was evaporated and the residue partitioned between water and ethyl acetate. Removal of the solvent from the dried organic layer left a residue consisting of crude allyl 5R,6S 6 1R hydroxyethyl 2 2 iodoethylthio penem 3 carboxylate, which was used as such in the following step. A solution of the above intermediate in dry tetrahydrofuran 25 ml was sequentially treated ice bath with pyridine 0.2 ml and silver perchlorate 175 mg . The reaction mixture was left rise to room temperature and the completition of the reaction was checked, at 30 minute intervals, by TLC. Most of the solvent was then removed in vacuo and the residue was taken up in CH₂Cl₂ and washed with cold 0.05M aqueous perchloric acid and then with water. The residue obtained from the dried organic layer was added to a solution of tetrabutylammonium fluoride trihydrate 1.7 g in tetrahydrofuran 25 ml . Acetic acid 1 ml was added and the mixture stirred overnight at room temperature Removal of the solvent and flash chromatography over silica CH₂Cl₂ MeCN, then aqueous MeCN afforded a somewhat impure sample of the allyl ester of the title product, which was directly treated with triphenylphospine 30 mg , PPh₃ ₄Pd 30 mg and acetic acid 0.3 ml in a tetrahydrofuran dichloromethane mixture. The progress of the reaction was monitored by TLC further amounts of PPh₃ and of the catalyst 5 mg each were added at 5 minute intervals until the starting material had disappeared. The catalyst was filtered off and the residue obtained upon evaporation was partitioned between water 1 ml and dichloromethane 1 ml . The aqueous layer was collected and passed through a reverse phase column, using water and finally aq. MeCN as eluants. Freeze drying of the appropriate fractions gave the title compound 45 mg IR ν max KBr 3400, 1755, 1605 cm ¹ NMR MH 8.3 8.6 2H, m, ppm. Operating as described in the previous example, the following compounds were analogously prepared A solution of allyl 5R, 6S 6 1R tert butyldimethylsilyloxyethyl 2 ethylsulphinyl penem 3 carboxylate prepared as described in Example 1 230 mg in dry acetonitrile 5ml was cooled under argon to 60 and treated in sequence with N 2 mercaptoethyl N methylmorpholinio trifluoromethanesulphonate 176 mg and diisopropylethylamine 0.12 ml . The reaction mixture was stirred for 30 minutes at 40 and then partitioned between 0.1N HCl and dichloromethane . The organic layer was washed with brine and the solvent removed , thus obtaining crude allyl 5R,6S 6 1R tert butyldimethylsilyloxyethyl 2 2 N methylmorpholinio ethylthio penem 3 carboxylate chloride, trifluoromethanesulphonate salts as a gum. This material was stirred with tetrabutylammonium fluoride trihydrate 470 mg and acetic acid 0.5 ml in tetrahydrofuran 10 ml for 18 hours at room temperature. After evaporation of the solvent, the residue was loaded on a silica column. Elution with CH₂Cl₂, then CH₂Cl₂ EtOH, then EtOH MeCN, and finally 35 aq. MeCN followed by removal of the solvent from the appropriate fractions, gave an aqueous solution of the allyl ester of the title product. After washing with ether and freeze drying, the obtained powder was taken up in tetrahydrofuran dichloromethane 1 1, 10 ml , PPh₃ 50 mg , PPh₃ ₄Pd 50 mg , and acetic acid 0.2 ml were added, and the mixture stirred for 1 hour at room temperature. The catalyst was filtered off and the solvent evaporated. The residue was dissolved in demineralized water 1 ml , washed with ethyl acetate 1 ml , and the aqueous solution passed through a reverse phase column LiChroprep RP 18 Merck . Elution with water and then with acetonitrile water, followed by freeze drying of the appropriate fractions, gave the title product as a white powder 40 mg IR ν max KBr 3400, 1760, 1605, 1570 cm ¹ NMR 60 MHz, D₂O 1.29 3H, d, J 6.5 Hz, Operating as described in the previous example, the following compounds were analogously prepared A solution of allyl 5R,6S 6 1R tert butyldimethylsilyloxyethyl 2 4 hydroxymethyl phenylthio penem 3 carboxylate 450 mg in dry dichloromethane 20 ml was stirred under argon with pyridine 0.7ml and trifluoromethanesulphonic anhydride 0.66 ml at 40 C for 30 minutes. The reaction mixture was poured into 0.1M HCl and the organic layer separated, washed with brine and evaporated. To the resulting gum there were added tetrahydrofuran 15 ml , acetic acid 1.5 ml , and tetrabutylammonium fluoride trihydrate 1.5 g . When the starting material had disappeared TLC monitoring, about 1 day at room temperature , the solvent was evaporated in vacuo and the residue was purified by flash chromatography over SiO₂ CH₂Cl₂ MeCN and then aqueous NeCN as eluants to afford salts chloride, acetate of allyl 5R, 6S 6 1R hydroxyethyl 2 4 pyridiniomethyl phenylthio penem 3 carboxylate 220 mg IR ν max film 3400, 1785, 1705 cm ¹. This material was taken up in a mixture of PPh₃ 23 mg , PPh₃ ₄ Pd 23 mg and acetic acid 0.3 ml in tetrahydrofuran dichloroetane 1 1, 15 ml . More catalyst was added at ten minutes intervals, until the reaction was judged complete by TLC. The mixture was filtered, the solvent removed in vacuo and the residue purified by reverse phase chromatography, eluting first with water and then with a gradient in acetonitrile. The β lactam containing fractions UV 300nm were collected and freeze dried to give the title compound as a white amorphous solid 95 mg IR νmax KBr 3400, 1760, 1600 cm ¹. Operating as described in the previous example, the following compounds were analogously obtained Allyl 5R,6S 6 1R tert butyldimethylsilyloxyethyl 2 4 hydroxymethylphenylthio penem 3 carboxylate was converted into allyl 5R,6S 6 1R tert butyldimethylsilyloxyethyl 2 4 iodomethylphenylthio penem 3 carboxylate by closely following the procedure described in Example 2. Without purification, this intermediate 250 mg was dissolved in dry dimethylformamide and stirred at 20 under nitrogen with nicotinamide 500 mg and silver perchlorate 120 mg . The reaction mixture was left to rise to room temperature while checking the progress of the reaction by TLC. Partition between dichloromethane and 0.05M aqueous hydrochloric acid followed by washing with water and brine of the organic layer, gave a solution of allyl 5R,6S 6 1R tert butyldimethylsilyloxyethyl 2 4 4 carbamoylpyridiniomethyl phenylthio penem 3 carboxylate IR ν max film 1795, 1705 sh, 1685 cm ¹. Desilylation of this material with tetrabutylammonium fluoride followed by deallylation with PPh₃ ₄Pd, as indicated in Example 7, furnished the title compound IR ν max KBr 3400, 1765, 1610 cm ¹. Operating as described in the previous example, the following compound was analogously obtained 5R,6S 6 1R hydroxyethyl 2 4 3 hydroxymethylpyridiniomethyl phenylthio penem 3 carboxylate 18 . A solution of p nitrobenzyl 5R,6S 6 1R tert butyldimethylsilyloxyethyl 2 4 hydroxymethyl phenoxy penem 3 carboxylate 320 mg in dry dichloromethane 15 ml was cooled at 70 under nitrogen. Pyridine 1.5 ml and trifluoromethanesulphonic anhydride 0.8 ml were added in sequence, and the mixture left rise to 30 C. The reaction mixture was quenched with 0.1N aqueous HCl and the separated organic layer was washed once with water, then dried Na₂SO₄ , concentrated to a small volume and taken up in dry tetrahydrofuran 20 ml . To this solution, acetic acid 1 ml and tetrabutylammonium fluoride trihydrate 1.0 g was added, and the mixture stirred for 20 hours at room temperature. Removal of the solvent and flash chromatography over silica aq. MeCN afforded the p nitrobenzyl ester of the title product IR ν max film 3400, 1790, 1710 cm ¹. This intermediate 200 mg was taken up in a mixture of tetrahydrofuran 20 ml and aq. NH₄Cl 5g in 20 ml . Iron powder 5g was added and the mixture vigorously stirred at 10 15 C until the reaction was judged complete by TLC H₂O MeOH NaCl 9 1 1 . The mixture was filtered, and the solvent was evaporated in vacuo to leave an aqueous solution of the crude title compound, which was isolated pure after reverse phase chromatography LiCroprep RP 18 Merck as a white powder 80 mg IR ν max KBr 3400, 1760, 1600 cm ¹. UV λ max H₂O 260, 303 nm NMR 200 MHz D₂O, 45 C δ 1.33 3H,d,J 6.5 Hz , 3.89 1H,dd, Operating as described in the previous example, the following compounds were analogously obtained